Las empresas constructoras españolas solidifican su sueño americano Ivar AI

Ambcrypto.com

Crypto market cap surpasses France, UK GDPs – India, Japan next

The Irish Times

Israel moves tanks into Golan Heights demilitarised zone and strikes ‘strategic targets’ in Syria

Www.abc.es

Alcobendas: segunda ciudad en facturación empresarial y multinacionales de España

Eleconomista.es

Una nueva bajada de tipos por parte del BCE, la cuarta en el año, sobrevuela los mercados

Biztoc.com

Google parent Alphabet’s shares surge after quantum computing breakthrough

Biztoc.com

2 Artificial Intelligence (AI) Stocks to Buy Right Now That Could Make You a Millionaire

The Atlantic

Khamenei Loses Everything

ETF Daily News

JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Lululemon Athletica (NASDAQ:LULU) Stock

Bitcoinist

Bitcoin Price Around $200,000 “Achievable” By 2025 End, Standard Chartered Says

Www.abc.es

Las empresas constructoras españolas solidifican su sueño americano

Zdnet.co.kr

애플, 사상 최고가...시총 3조7000억 달러 돌파

ABC News

Five years since its inception, a US development agency competes with China on global projects

Excelsior.com.mx

Economía circular: del reciclaje del aluminio al valor agregado

Shtfplan.com

WEF Survey Shows That Business Leaders Are Deeply Concerned That A Global Recession Is Coming

Cnbeta.com.tw

美国新国防立法旨在让华为无法从国防部承包商获得芯片技术

Bleeding Cool News

Moana 2 Powers Another Weekend Box Office Of Records

Bitcoinist

These 7 Cryptos Could Explode This December, Say Specialists

Biztoc.com

Stock Markets Extends Record Highs, US Labor Market Recovers, Bitcoin Hits $100,000: This Week In The Markets

Noticiaslatam.lat

¿Cómo la industria automotriz de China podría afectar al mercado mundial del petróleo?

BeInCrypto

Tether acuña $19 mil millones en USDT en un mes y genera debates en el mercado cripto

$Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma$

GlobeNewswire

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma